Alfresa Holdings Corporation (ALFRY)

Market Cap	2.45B
Revenue (ttm)	19.77B
Net Income (ttm)	182.90M
Shares Out	n/a
EPS (ttm)	0.99
PE Ratio	13.38
Forward PE	n/a
Dividend	0.43 (2.69%)
Ex-Dividend Date	Mar 28, 2025

Volume	100
Average Volume	6
Open	15.99
Previous Close	15.99
Day's Range	15.99 - 15.99
52-Week Range	13.42 - 15.99
Beta	0.20
RSI	100.00
Earnings Date	Aug 6, 2025

About Alfresa Holdings

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements,...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2003
• Employees: 12,517
• Stock Exchange: OTCMKTS
• Ticker Symbol: ALFRY

Financial Performance

In 2024, Alfresa Holdings's revenue was 2.96 trillion, an increase of 3.59% compared to the previous year's 2.86 trillion. Earnings were 27.39 billion, a decrease of -7.34%.

Financial numbers in JPY